(Q35993083)

11 August 2017

In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells (English)

1 reference

11 August 2017

0 references

Ripamonti M

1

1 reference

11 August 2017

Pezzoni G

2

1 reference

11 August 2017

Pesenti E

3

1 reference

11 August 2017

Pastori A

4

1 reference

11 August 2017

Farao M

5

1 reference

11 August 2017

Bargiotti A

6

1 reference

11 August 2017

Suarato A

7

1 reference

11 August 2017

Spreafico F

8

1 reference

11 August 2017

Grandi M

9

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 May 1992

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

65

1 reference

11 August 2017

5

1 reference

11 August 2017

703-707

1 reference

Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

The multidrug resistance phenotype

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

The cell biology of multiple drug resistance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

The biochemistry of P-glycoprotein-mediated multidrug resistance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

Novel anthracycline analogs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

Multidrug resistance and its circumvention

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicin

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

Multidrug resistance: molecular biology and clinical relevance.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

Effect of MX2, a new morpholino anthracycline, against experimental brain tumors.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

Influence of lipophilicity on cytotoxicity of anthracyclines in LoVo and LoVo/Dx human cell lines

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977399

Expression of a multidrug resistance gene in human cancers

11 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1586598

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Activity of adriamycin (NSC-123127) and daunomycin (NSC-82151) against mouse mammary carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1586598

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1992.148

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

PubMed publication ID

1586598

1 reference